Quantcast

Latest Lipids Stories

2014-05-14 20:23:53

WOODBRIDGE, ON, May 14, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF)(CSE:PVO) ("Pivotal" or "the Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, today announced changes to its Board designed to increase its independence and enhance Pivotal's corporate governance at this stage of the Company's development. Dr. Jackowski has stepped down as Chairman of Pivotal Therapeutics Inc. effective May...

2014-05-13 16:28:03

"Phytoceramides", this complex sounding word that has been heard everywhere recently, describes the newest innovation in anti-aging skin supplement. MIAMI, May 13, 2014 /PRNewswire/ -- What exactly are Phytoceramides and why is everyone talking about them? According to PhytoPearl's spokesperson, the enthusiasm for these wonder compounds has been growing since they started being called "the natural alternative to a facelift". Here are the facts and the science behind all the excitement: Photo...

2014-05-13 16:27:44

WOODBRIDGE, ON, May 13, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced that it has engaged Brandkarma LLC., an award winning, US-based, healthcare marketing and brand specialist with global expertise to support the Company's commercialization strategy for VASCAZEN(®). "VASCAZEN(®) represents a much-needed solution for...

2014-05-12 08:28:11

BOSTON, May 12, 2014 /PRNewswire/ -- Verde Media Group Inc. (OTC:VMGI) and its Biotech Division ("VMBD") announces that Butazyme, LLC, "BTZ" a wholly owned company of VMBD, has broken ground and commenced construction of the omega-3 project site in Asia. The joint venture with Phoenix Energy "PXE" is fully financed and involves scaling and co-developing the BTZ omega-3 technology to 20,000 liters in phase-I. BTZ has developed a proprietary microbial technology to produce high value...

2014-05-07 23:14:17

“Health And Beauty Benefits Of Fish Oil Supplements For Men And Women,” a new report on the website Vkool.com uncovers health and beauty benefits of fish oil, and some reasons to love it. Seattle, WA (PRWEB) May 07, 2014 “Health And Beauty Benefits Of Fish Oil Supplements For Men And Women,” a new report created by Hafizur on the site Vkool.com shows fish oil benefits on health, skin and hair, and detailed instructions on how to use it properly. In the first part of this report,...

2014-05-07 12:30:30

WOODBRIDGE, ON, May 7, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today that the U.S. Patent and Trademark Office (USPTO) has issued Patent Number 8,715,648 titled "Formulations Comprising Omega-3 Fatty Acids and Anti-Obesity Agent for the Reduction of Body Weight in Cardiovascular Disease Patients (CVD) and Diabetics"....

2014-05-06 16:31:55

WOODBRIDGE, ON, May 6, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, is pleased to announce that it presented two posters at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) 2014 Scientific Sessions held in Toronto, Ontario, Canada, May 1-3, 2014. Both posters discussed Omega-3 deficiency (OM3D)...

2014-05-05 08:27:56

SBIR Grant from the National Institutes of Neurological Diseases and Stroke Provides Funds for IND-enabling Studies of Lpathomab SAN DIEGO, May 5, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, received official notification from the National Institutes of Neurological Diseases and Stroke (NINDS) that it has been awarded a $1.7 million, 2.5-year grant to develop its antibody therapeutic, Lpathomab(TM), which is directed...

2014-05-01 16:31:22

WOODBRIDGE, ON, May 1, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, is pleased to announce that it will be presenting two posters at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) 2014 Scientific Sessions in Toronto, Ontario, Canada, May 1-3, 2014. The first poster entitled "Correlation...

2014-05-01 16:31:16

WOODBRIDGE, ON, May 1, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announces a correction to its press release issued yesterday entitled "Pivotal Therapeutics Announces 2013 Financial Results". The decrease in the loss from 2012 to 2013 of $745,342 was inadvertently overstated by $91,520. The correct decrease in loss is $653,822 and...


Latest Lipids Reference Libraries

Vistive Gold
2013-10-02 12:54:36

Vistive Gold, MON 87705, is a genetically engineered variety of glyphosate-resistant low-linolenic, high-oleic soybeans created by Monsanto. Vistive Gold was designed to be a replacement for hydrogenated oils and fats, which are high in trans-fatty acids. The decreased linolenic content enables Vistive Gold to have favorable traits for deep frying and increasing the shelf life of foods. The Federal Register declared on June 28, 2011 that Monsanto was petitioning the Animal and Plant...

More Articles (1 articles) »
Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related